SUPERDROL 15

Methasterone Tablets

(also known as Methyldrostanolone)

PRODUCT NAME & PACKAGING

Brand Name: SUPERDROL 15
Generic Name: Methasterone (also referred to as methyldrostanolone)
Strength & Packaging: 50 tablets per tub | 15 mg per tablet

Methasterone is described in NIH/PubChem sources as an orally active anabolic-androgenic steroid and is also associated with the name Superdrol.

DESCRIPTION

SUPERDROL 15 contains methasterone, a synthetic oral anabolic-androgenic steroid. NIH-reviewed literature describes methasterone as a 17α-alkylated orally active analogue of drostanolone, a structural feature that helps oral activity but is also associated with higher liver-toxicity risk in this steroid class.

INDICATIONS

For a medical-reference entry, the safest wording is that no standard therapeutic indication is established in the reviewed medical/regulatory sources. NIH-reviewed literature classifies methasterone among designer steroids and notes that it was illicitly used as the main ingredient of a dietary supplement named Superdrol, rather than presented as a routinely approved medicinal product.

DOSAGE & ADMINISTRATION

Route: Oral administration

Because the reviewed sources describe methasterone as a designer steroid rather than a standard approved drug with a public prescribing monograph, a universal medical dosage should not be stated as though it were an established reference product. A suitable catalog wording is:

“Administer only under the direction of a licensed healthcare professional and in accordance with the manufacturer’s labeling, applicable regulations, and patient-specific clinical judgment.”

MECHANISM OF ACTION

Methasterone belongs to the anabolic-androgenic steroid class and is described in the literature as an orally active anabolic agent exhibiting androgenic activity. As with other agents in this class, its effects are mediated through androgen-related signaling, with the 17α-alkylated structure contributing to oral bioavailability.

PRECAUTIONS

Use requires careful professional oversight. FDA warns that products labeled to contain steroid or steroid-like substances have been linked to serious liver injury requiring hospitalization, and also notes broader risks including abnormal fat/cholesterol levels, mood disorders, androgenic effects, gonadal suppression, and gynecomastia. NIH-reviewed literature additionally describes methasterone as exhibiting strong hepatotoxicity.

SIDE EFFECTS

Potential adverse effects associated with methasterone and related anabolic-androgenic steroids include cholestatic liver injury, jaundice, lipid abnormalities, mood changes, androgenic effects such as acne or hair changes, testicular suppression, and gynecomastia. A published case series specifically reported that methasterone use can result in severe hepatotoxicity.

STORAGE

Store according to the manufacturer’s labeled instructions and keep the product in its original container. Because methasterone is described in the reviewed literature as a designer steroid / supplement-associated substance rather than a standard approved medicine, a standardized public monograph storage instruction was not identified in the sources reviewed.